Found: 8
Select item for more details and to access through your institution.
Mosaic and mixed HIV-1 glycoprotein nanoparticles elicit antibody responses to broadly neutralizing epitopes.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 10, p. 1, doi. 10.1371/journal.ppat.1012558
- By:
- Publication type:
- Article
Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas.
- Published in:
- Cancers, 2018, v. 10, n. 4, p. 89, doi. 10.3390/cancers10040089
- By:
- Publication type:
- Article
A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32232-0
- By:
- Publication type:
- Article
Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00862-8
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs.
- Published in:
- European Journal of Immunology, 2022, v. 52, n. 4, p. 646, doi. 10.1002/eji.202149656
- By:
- Publication type:
- Article
Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies.
- Published in:
- Vaccines, 2019, v. 7, n. 3, p. 76, doi. 10.3390/vaccines7030076
- By:
- Publication type:
- Article
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.
- Published in:
- eLife, 2021, p. 1, doi. 10.7554/eLife.70330
- By:
- Publication type:
- Article
A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00411-7
- By:
- Publication type:
- Article